Citigroup Inc Bausch & Lomb Corp Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$16.8 - $20.99 $490,274 - $612,551	-29,183 Reduced 95.56%	1,357 $23,000
Q2 2023 Aug 10, 2023	BUY	$16.03 - $20.07 $466,905 - $584,578	29,127 Added 2061.36%	30,540 $612,000
Q1 2023 May 11, 2023	SELL	$15.67 - $18.91 $460,024 - $555,140	-29,357 Reduced 95.41%	1,413 $24,000
Q4 2022 Feb 09, 2023	SELL	$13.5 - $17.14 $1.4 Million - $1.78 Million	-103,828 Reduced 77.14%	30,770 $477,000
Q3 2022 Nov 10, 2022	BUY	$14.23 - $17.76 $1.83 Million - $2.29 Million	128,850 Added 2241.65%	134,598 $2.08 Million
Q2 2022 Aug 10, 2022	BUY	$13.36 - $20.0 $76,793 - $114,960	5,748 New	5,748 $88,000

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.